Interrelation study between drugs and oral lesion development in patients with special needs

Authors

  • Briana Góes Monteiro Escola Bahiana de Medicina e Saúde Pública
  • Maria Cecília Fonsêca Azoubel Escola Bahiana de Medicina e Saúde Pública
  • Juliana Borges de Lima Dantas Faculdade Adventista da Bahia https://orcid.org/0000-0002-9798-9016
  • Alena Ribeiro Alves Peixoto Medrado Escola Bahiana de Medicina e Saúde Pública

DOI:

https://doi.org/10.5935/2525-5711.20180024

Keywords:

Disabled Persons, Pathology, Oral, Pharmacology, Mouth Mucosa, Metabolic Side Effects of Drugs and Substances

Abstract

Introduction: Special dentistry is an area that of dentistry that concerns itself with tre- ating patients with special needs. To greater knowledge of the specific special needs by the dentist, there is an urgent need to emphasize the importance of proper odontologic treatment, whether in office or in a hospital environment to this population Objectives: The aim of this study was to correlate the use of drugs in patients with special needs with the development of oral lesions and to better characterize this population. Materials and Methods: This was a quantitative and qualitative cross-sectional study which included special needs patients from the Brazil’s Universal Health-Care System. Analysis of medical records and intraoral physical examination was performed for 88 patients and descriptive data was extracted. Results: The patient population was predominantly female (54.5%) and older than 18 years of age (62.5%). A higher frequency of neurological and psychomotor disorders (54.5%), hypertension (29.5%) and diabetes mellitus (15.9%) was found. A total of 21.6% patients reported a”dry mouth.” sensation. The drugs most frequently used were anticonvulsants (46.5%), anxiolytics (35.2%) and anti-hypertensives (34%). The highest percentage of lesions corresponded to gingival enlargement (19.3%), followed by gingivitis (10.2%) and candidiasis (7.9%). Conclusion: It is expected that results derived from this research can contribute to a better understanding of the interrelationship between the use of pharmaceutical agents and the appearance of lesions in the oral mucosa, as well as to indirectly improve oral health of certain patient populations.

Author Biographies

Briana Góes Monteiro, Escola Bahiana de Medicina e Saúde Pública

Cirurgia

Maria Cecília Fonsêca Azoubel, Escola Bahiana de Medicina e Saúde Pública

Estomatologia

Juliana Borges de Lima Dantas, Faculdade Adventista da Bahia

Estomatologia

Alena Ribeiro Alves Peixoto Medrado, Escola Bahiana de Medicina e Saúde Pública

Processo Interativo Orgaos e Sistemas

References

Campos CC, Frazao BB, Saddi GL, Morais LA, Ferreira MG, Setúbal PCO, et al. Pacientes com necessidades especiais: quem sao? In: Campos CC, Frazao BB, Saddi GL, Morais LA, Ferreira MG, Setúbal PCO, et al. Manual prático para o atendimento odontológico de pacientes com necessidades especiais. 2ª ed. Goiânia: Universidade Federal de Goiás; 2009. p. 1-6.

Dehaitem MJ, Ridley K, Kerschbaum WE, Inglehart MR. Dental hygiene education about patients with special needs: a survey of U.S. programs. J Dent Educ. 2008;72:1010-9.

Krause M, Vainio L, Zwetchkenbaum S, Inglehart MR. Dental education about patients with special needs: a survey of U.S. and canadian dental schools. J Dent Educ. 2010;74:1179-89.

Oliveira AC, Czeresnia D, Paiva SM, Campos MR, Ferreira EF. Utilization as oral health care for Down syndrome patients. Rev Saúde Pública. 2008;42:693-9.

Little JW, Falace DA, Miller CS, Rodhus NL. Manejo odontológico do paciente clinicamente comprometido. 7ª ed. Rio de Janeiro: Elsevier; 2008.

Bertoli LCF, Ferronato T. Perfil dos Pacientes com Necessidades Especiais Atendidos na Faculdade de Odontologia da Universidade Federal do Rio Grande do Sul [Trabalho de Conclusao de Curso]. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2009.

Oliveira FAF, Fernandes CP, Chaves FN, Magro LB, Sousa FB, Osterne RLV. Evaluation of oral diseases in a population of special needs patients. Rev Gaúcha Odontol. 2013;61:77-83.

Santos CML, Falcao MML, Souza ALD, Santos MS, Coelho AA. Perfil Epidemiológico dos Pacientes com Necessidades Especiais Atendidos em um Centro de Especialidades Odontológicas do Interior Baiano. Rev Baiana Saúde Pública. 2014;38:83-94.

Amaral SM, Miranda AMMA, Pires FR. Reaçoes medicamentosas na cavidade oral: aspectos relevantes na estomatologia. Rev Bras Odontol. 2009;66:41-53.

van der Putten GJ, Brand HS, Bots CP, van Nieuw Amerongen A. Prevalentie van xerostomie en hyposalivatie in een verpleeg-huis em de relatie met voorgeschreven medicatie. Tijdschr Gerontol Geriatr. 2003;34:30-6.

Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2015;11:45-51.

Guobis Z, Basevičienė N, Paipalienė P, Sabalys G, Kubilius R. Burnos sausumas: klinika, etiologija, diagnose ir gydymas. Medicina (Kaunas). 2006;42:171-9.

Greenspan D. Xerostomia and Management. Oncology. 1996;10(Suppl):7-11.

Falcao DP, Mota LMH, Pires AL, Bezerra ACB. Sialometria: aspectos de interesse clínico. Rev Bras Reumatol. 2013;53:525-31.

Veríssimo AH, Azevedo ID, Rêgo DM. Perfil Odontológico de Pacientes com Necessidades Especiais Assistidos em Hospital Pediátrico de uma Universidade Pública Brasileira. Pesq Bras Odontoped Clin Integr. 2013;13:329-35.

Haas NAT, Alves UM, Rocha VCF. O desafio do diagnóstico oral em pacientes especiais. Rev Fac Odontol. 2009;14:211-5.

Lin K, Guilhoto LMFF, Yacubian EMT. Drug-induced gingival enlargement - Part II. Antiepileptic drugs: not only phenytoin is involved. J Epilepsy Clin Neurophysiol. 2007;13:83-8.

Paz OAG, Brito VF, Xerfan SEM. Hipertrofia gengival induzida por anlodipina. Rev Bras Clin Med. 2011;9:150-3.

Rivarola Céspedes RD. Agrandamientos gingivales inducidos por fármacos. Rev Fundac Juan Jose Carraro. 2012;36:14-9.

Chacko LN, Abraham S. Phenytoin-induced gingival enlargement. BMJ Case Rep. 2014;2014. pii: bcr2014204670.

Colombo AL, Guimaraes T, Camargo LF, Richtmann R, Queiroz-Telles Fd, Salles MJ, et al. Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical. Braz J Infect Dis. 2013;17:283-312.

Otero Rey E, Peñamaría Mallón M, Rodríguez Piñón M, Martín Biedma B, Blanco Carrión A. Oral candidosis in the older patient. Av Odontoestomatol. 2015;31:135-48.

Bianchi CMPC, Bianchi HA, Tadano T, Paula CR, Hoffmann-Santos HD, Leite DP Jr, et al. Factors Related to Oral Candidiasis in Elderly Users and Non-Users of Removable Dental Prostheses. Rev Inst Med Trop Sao Paulo. 2016;58:17.

Medrado AP, Silva DARC, Wanderley FGC. Estudo da Prevalência de Lesoes em Mucosa Oral de Pacientes Portadores de Necessidades Especiais. Rev Bahiana Odontol. 2015;6:73-80.

Downloads

Published

2019-01-15

How to Cite

1.
Monteiro BG, Azoubel MCF, Dantas JB de L, Medrado ARAP. Interrelation study between drugs and oral lesion development in patients with special needs. J Oral Diagn [Internet]. 2019 Jan. 15 [cited 2024 Sep. 19];4:1-6. Available from: https://jordi.com.br/revista/article/view/116

Issue

Section

Original Article